◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items

REVOLUTION MEDICINES, INC.

CIK: 1628171 SIC: 2836
-
Revenue
$-1.13B
Net Income
-
Gross Margin
-
Op. Margin
$-1.54B
Free Cash Flow
Financial Statements Annual (10-K)
Showing 5 of 6 annual reports available (2020 - 2025)
Breakdown TTM
(Dec 31, 2025)
FY 2025
(Dec 31, 2025)
FY 2024
(Dec 31, 2024)
FY 2023
(Dec 31, 2023)
FY 2022
(Dec 31, 2022)
FY 2021
(Dec 31, 2021)
+ Total Revenue - - - $11.58M $35.38M $29.39M
Revenue Growth % nan% nan% -100.0% -67.3% 20.4% nan%
Operating Expenses $1.18B $1.18B $689.52M $498.76M $293.66M $217.40M
Research & Development $987.33M $987.33M $592.23M $423.14M $253.07M $186.95M
+ Operating Income $-1.18B $-1.18B $-689.52M $-487.19M $-258.28M $-188.01M
Operating Margin % nan% nan% nan% -4207.1% -730.0% -639.7%
Interest Expense - $24.23M - - - $12.00K
Interest Income $90.69M $90.69M $86.88M $47.48M $9.15M $929.00K
Other Income/Expense $13.65M $51.07M $88.68M $47.29M $9.15M $917.00K
Income Before Tax $-1.13B $-1.13B $-600.85M $-439.89M $-249.12M $-187.09M
Income Tax Expense - - $-753.00K $-3.52M $-420.00K -
+ Net Income $-1.13B $-1.13B $-600.09M $-436.37M $-248.71M $-187.09M
Net Margin % nan% nan% nan% -3768.3% -703.0% -636.6%
Basic EPS -5.94 -5.95 -3.58 -3.86 -3.08 -2.57
Diluted EPS -5.94 -5.95 -3.58 -3.86 -3.08 -2.57
Basic Shares Outstanding - 190.1M 167.7M 113.1M 80.6M 72.8M
Diluted Shares Outstanding - 190.1M 167.7M 113.1M 80.6M 72.8M
Breakdown FY 2025
(Dec 31, 2025)
FY 2024
(Dec 31, 2024)
FY 2023
(Dec 31, 2023)
FY 2022
(Dec 31, 2022)
FY 2021
(Dec 31, 2021)
Cash & Cash Equivalents $383.75M $543.06M $696.15M $161.41M $108.50M
Short-term Investments $1.64B $1.75B $1.16B $483.53M $468.56M
Other Current Assets $49.36M $38.33M $25.07M $10.57M $6.79M
Total Current Assets $2.08B $2.33B $1.88B $660.18M $589.77M
Property Plant & Equipment $33.19M $24.29M $22.86M $18.66M $11.54M
Goodwill $14.61M $14.61M $14.61M $14.61M $14.61M
Intangible Assets $55.80M $56.67M $57.74M $58.81M $59.88M
Other Non-current Assets $14.78M $13.87M $7.03M $2.86M $758.00K
Total Assets $2.35B $2.56B $2.06B $811.93M $737.99M
Accounts Payable $64.62M $54.43M $61.79M $21.31M $14.06M
Accrued Liabilities $5.00M - - - -
Deferred Revenue - - - $4.46M $12.36M
Other Current Liabilities $7.86M $583.00K - - -
Total Current Liabilities $290.42M $163.91M $143.85M $61.98M $60.35M
Deferred Tax Liabilities $2.35M $2.35M $3.12M $7.03M $7.44M
Other Non-current Liabilities $1.21M $670.00K $1.46M $301.00K $634.00K
Total Liabilities $723.21M $293.10M $235.51M $126.74M $135.42M
Common Stock $19.00K $18.00K $16.00K $9.00K $8.00K
Retained Earnings $-2.87B $-1.74B $-1.14B $-701.34M $-452.64M
Total Stockholders Equity $1.63B $2.27B $1.83B $685.19M $602.57M
Total Liabilities & Equity $2.35B $2.56B $2.06B $811.93M $737.99M
Breakdown TTM
(Dec 31, 2025)
FY 2025
(Dec 31, 2025)
FY 2024
(Dec 31, 2024)
FY 2023
(Dec 31, 2023)
FY 2022
(Dec 31, 2022)
FY 2021
(Dec 31, 2021)
Net Income $-1.34B $-1.13B $-600.09M $-436.37M $-248.71M $-187.09M
Depreciation & Amortization - - - - $3.97M $3.08M
Stock-based Compensation $197.39M $118.39M $79.20M $61.77M $31.20M $20.72M
Deferred Income Tax - - $-738.00K $-3.85M - -
Change in Receivables - - $-1.25M $-3.42M $-1.26M $-464.00K
Change in Payables $1.76M $9.54M $-6.46M $32.47M $7.29M $2.24M
Operating Cash Flow $-1.51B $-897.74M $-557.44M $-350.57M $-224.40M $-147.18M
Capital Expenditure $29.97M $15.99M $10.31M $7.73M $10.82M $6.53M
Purchases of Investments $3.34B $1.79B $2.14B $1.06B $612.77M $671.34M
Investing Cash Flow $120.44M $118.06M $-554.39M $-342.60M $-24.12M $-142.12M
Stock Issued - - $727.62M $323.71M $248.13M $281.14M
Financing Cash Flow $879.86M $621.52M $959.41M $1.23B $301.43M $294.18M
Net Change in Cash $-508.08M $-158.16M $-152.42M $536.03M $52.91M $4.88M
SEC Filing Format - Data shown as it appears in the Q3 2025 (10-Q) filing Period ended: Sep 30, 2025
Condensed Consolidated Statements of Operations
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Operating Expenses $315.27M - $820.74M -
Research & Development $262.51M - $692.39M -
Operating Income $-315.27M - $-820.74M -
Interest Expense $11.43M - $12.29M -
Interest Income $22.08M - $69.40M -
Other Income/Expense - - $-42.00K -
Income Before Tax $-305.21M - $-766.41M -
Net Income $-305.21M $-133.23M $-766.41M -
Basic EPS -1.61 - -4.06 -
Diluted EPS -1.61 - -4.06 -
Basic Shares Outstanding $189.23M - $188.66M -
Diluted Shares Outstanding $189.23M - $188.66M -
Condensed Consolidated Balance Sheets
Description Sep 30, 2025 Dec 31, 2024
Cash & Cash Equivalents $217.44M $543.06M
Short-term Investments $1.71B $1.75B
Other Current Assets $45.98M $38.33M
Total Current Assets $1.98B $2.33B
Property Plant & Equipment $32.93M $24.29M
Goodwill $14.61M $14.61M
Intangible Assets $55.87M $56.67M
Other Non-current Assets $14.87M $1.74M
Total Assets $2.25B $2.56B
Accounts Payable $74.85M $54.43M
Total Current Liabilities $245.62M $163.91M
Deferred Tax Liabilities $2.35M $2.35M
Other Non-current Liabilities $2.48M $670.00K
Total Liabilities $655.02M $293.10M
Common Stock $18.00K $18.00K
Retained Earnings $-2.50B $-1.74B
Total Stockholders Equity $1.60B $2.27B
Total Liabilities & Equity $2.25B $2.56B
Condensed Consolidated Statements of Cash Flows
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Net Income $-305.21M $-133.23M $-766.41M -
Stock-based Compensation - - $84.69M -
Change in Receivables - - - -
Change in Payables - - $20.04M -
Operating Cash Flow - - $-623.50M -
Capital Expenditure - - $14.06M -
Purchases of Investments - - $1.50B -
Investing Cash Flow - - $43.18M -
Financing Cash Flow - - $255.87M -
Net Change in Cash - - $-324.46M -

All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-K filings.

Annual data represents full fiscal year results. FY = Fiscal Year ending.

NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...